Hexaware. 2QCY17 Result Update. Margin pressure ahead, rich valuations. Sector: Technology CMP: ` 262. Recommendation: Hold

Similar documents
Hexaware. 4QCY18 Result Update. Margin miss, rich valuations. Sector: Technology CMP: ` 322. Recommendation: Hold

Hexaware. 1QCY16 Result Update. Remaining of CY16 to be better, Rich valuations. Sector: Technology CMP: `227. Recommendation: Hold

Mphasis. 1QFY18 Result Update. Margins dip; valuations not supportive. Sector: Technology CMP: ` 614. Recommendation: Sell

NIIT Technologies. 3QFY19 Result Update. Robust revenue visibility, Outlook robust

NIIT Technologies. 2QFY19 Result Update. Robust revenue visibility, Outlook robust

KPIT. 1QFY18 Result Update. Profitability does it again, looking for sustenance. Sector: Technology CMP: ` 130. Recommendation: Hold

Tech Mahindra. 4QFY17 Result Update. Short term blip, compelling valuation. Sector: Technology CMP: ` 429. Recommendation: Buy

NIIT Technologies. 4QFY17 Result Update. Robust revenue visibility, Margin expansion story intact. Sector: Technology CMP: `471. Recommendation: Buy

Persistent Systems. Analyst Meet Update. Futuristic technologies, short term hazy, Hold. Sector: Technology CMP: ` 655. Recommendation: Hold

Tech Mahindra. 1QFY18 Result Update. Steps in the right direction, compelling valuation. Sector: Technology CMP: ` 385. Recommendation: Buy

Mphasis. 1QFY17 Result Update. Muted quarter, Direct business still weak. Sector: Technology CMP: ` 540. Recommendation: Sell

NIIT Technologies. Analyst Meet Update. Non-linearity to boost revenues, margins. Sector: Technology CMP: `496. Recommendation: Buy

Nestlé India. Q2CY17 Result Update. Positives priced in; Downgrade to Hold. Sector: FMCG CMP: ` 6,786. Recommendation: HOLD

Infosys. 3QFY19 Result Update. Decent quarter; Strong deal wins. Sector: Technology CMP: ` 684. Recommendation: Buy

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD

Wipro. 3QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 328. Recommendation: Hold

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD

Havells India. Q1FY18 Result Update Strong Sales growth; Margins decline. Sector: Consumer Durable CMP: ` 467. Recommendation: BUY

TTK Prestige. Q2FY18 Result Update Healthy Sales growth; Margins expands. Sector: Consumer Durable CMP: ` 6,145. Recommendation: HOLD

Infosys. 4QFY18 Result Update. Decent quarter; margin guidance disappoints

Havells India. Q4FY17 Result Update Strong Sales growth; Margins stable. Sector: Consumer Durable CMP: ` 515. Recommendation: BUY

ITC. 1QFY18 Result Update Higher Excise duty impacts sales; healthy EBITDA margin. Sector: FMCG CMP: ` 289. Recommendation: BUY

Wipro. 3QFY17 Result Update. Guidance subdued, maintain Hold. Sector: Technology CMP: ` 474. Recommendation: Hold

HUL. Q4FY17 Result Update Healthy performance, rich valuations. Sector: FMCG CMP: ` Recommendation: Hold

Symphony. Q3FY18 Result Update Strong performance; valuations expensive. Sector: Consumer Durable CMP: ` 1,970. Recommendation: HOLD

Hindustan Unilever. Q4FY18 Result Update Strong volume growth on weak base and uptick in rural. Sector: FMCG CMP: ` 1,516. Recommendation: HOLD

Wipro. 1QFY17 Result Update. Disappointing outlook, margin decline negative, Hold. Sector: Technology CMP: ` 549. Recommendation: Hold

Hindustan Unilever. Q1FY19 Result Update Maintaining strong volume trajectory on high base is the key. Sector: FMCG CMP: ` 1,644. Recommendation: HOLD

Dabur India Ltd. Q3FY18 Result Update Strong Volume led Domestic growth; IBD remains weak. Sector: FMCG CMP: ` 356. Recommendation: BUY

Consumer. 4QFY19 Results Preview Stronger earnings growth but moderating volumes

Consumer. 3QFY19 Results Preview Expect stable volume led revenue growth in festive quarter

Technology. Sector Update Traditional sourcing growth forecast at 4.5% for CY19. Nifty vs CNX IT

Bajaj Corp Q2FY18 Result Update ADHO volume picks up; Nomarks to perform in coming qtrs

Zee Entertainment. 1QFY19 Result Update Domestic advertisement to surpass initial estimates

Zee Entertainment. 1QFY17 Result Update Strong advertisement revenue, maintain Buy. Sector: Media CMP: ` 474. Recommendation: Buy

Nestlé India. Q4CY16 Result Update. Healthy Sales growth; higher provisions & CSR impacts bottom-line. Sector: FMCG CMP: ` 6,169. Recommendation: BUY

Zee Entertainment. 4QFY16 Result Update Strong advertisement revenue, maintain Buy. Sector: Media CMP: ` 417. Recommendation: Buy

Hexaware Technologies

Zee Entertainment. 3QFY17 Result Update Best ever margin, rich valuations. Sector: Media CMP: ` 480. Recommendation: Hold

Hexaware Technologies Ltd IT SELL RETAIL EQUITY RESEARCH. 21 st September 2018 Q2CY18 RESULT UPDATE. CMP Rs. 447 TARGET Rs.

Colgate-Palmolive. Q3FY17 Result Update Steep decline in Sales; EBITDA margin contraction continues. Sector: FMCG CMP: ` 879. Recommendation: HOLD

Havells India. Q3FY17 Result Update Positive surprise; Maintain Buy. Sector: Consumer Durable CMP: ` 376. Recommendation: BUY.

Amber Enterprises India Ltd

Tata Consultancy Services (TCS)

Havells India. Q4FY16 Result Update In-line result; Consistent improvement in performance. Sector: Consumer Durable CMP: ` 342. Recommendation: BUY

Previous Recommendation: Neutral QUARTERLY PERFORMANCE (INDIAN GAAP)

ITC. Q1FY17 Result Update Healthy Operational Performance; Maintain BUY. Sector: FMCG CMP: ` 251. Recommendation: BUY

Lupin Ltd. RESULT UPDATE 31 st October 2017

KPIT CUMMINS INFOSYSTEMS Ltd.

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Nestlé India Outlook Hazy; Valuations Prohibitive

Visaka Industries Ltd

Wipro ACCUMULATE. Performance Highlights CMP. `539 Target Price `582. 1QFY2017 Result Update IT. Investment Period 12 Months

Nestle India Ltd. RESULT UPDATE

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Cipla Ltd. RESULT UPDATE

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Hexaware Technologies (HEXW IN)

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Larsen & Toubro Ltd.

Mahindra & Mahindra Ltd.

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Fineotex Chemical Ltd

Near-term pressure, but long-term outlook positive

Mahindra & Mahindra Ltd.

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Wipro BUY. Performance Highlights. CMP Target Price `539 `680. 4QFY2016 Result Update IT. 3-year price chart. Key financials (Consolidated, IFRS)

Financial Release June 30, 2018

Growth USD Mn. Q1 18 QoQ YoY Revenue (Constant Currency ) % 10.1%

Hexaware Reports Fourth Quarter and FY 2017 results. FY 2017 revenue at $607.5 mn; up 15.6% YoY. Profitability Outgrows Revenue

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

NIIT Technologies Ltd. (NIIT Tech)

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Hindustan Media Ventures

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Lupin Ltd. RESULT UPDATE

Symphony Ltd. RESULT UPDATE 31st October 2017

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Religare Investment Call

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

Cummins India Ltd Bloomberg Code: KKC IN

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Transcription:

Hexaware 2QCY17 Result Update Margin pressure ahead, rich valuations Sector: Technology CMP: ` 262 Recommendation: Hold Market statistics Current stock price (`) 262 Shares O/S (cr.) 29.7 Mcap (` cr) 7,774 52W H/L (`) 268/178 6m avg. volume 1,236,983 Bloomberg HEXW IN Shareholding pattern Promoters 71.45 Domestic Institution 8.69 Foreign Institution 10.62 Non-institution 9.24 of which more than 1% HDFC TRUSTEE CO.LTD-A/C HDFC MICCAP 6.18 T ROWE Price International Discovery Fund 2.25 Hexaware vs Nifty 120 110 100 90 80 Hexaware Capital efficiency & valuations Nifty 70 Jul-16 Nov-16 Mar-17 Jul-17 Particulars CY16 CY17E CY18E RoE (%) 28.1 28.3 28.1 EPS (`) 14.6 15.5 17.0 CEPS (`) 16.4 19.1 20.9 P/E (x) 13.5 16.9 15.4 P/BV (x) 3.5 4.2 3.7 EV/EBITDA (x) 9.0 10.5 9.1 Income growth (%) 13.2 12.3 10.9 EBITDA growth (%) 7.9 14.6 12.3 PAT growth (%) 6.9 14.0 10.6 ANALYST Naushil Shah +91-22 4224 5125 naushil.shah@trustgroup.co.in Hexaware s quarterly result was higher-than-expectation. The company s Q2CY17 revenue at US$152.6mn, up 4.9% in cc terms QoQ. Volume growth was 6.4% QoQ. Company won new business worth TCV of US$40mn this quarter (US$120mn in CY15, US$153mn in CY16, US$65mn in 1HCY17). HEXW has invested in sales and marketing engine in CY15-16 to build base for future growth. We maintain our rating on the stock at Hold on account of rich valuations. HEXW's decision to develop core competence and differentiation in key areas - Capital Markets, Travel and Transportation, EAS and Testing - is the right approach for a relatively small player trying to develop a niche for itself. Pressure on margin front going ahead. Q2CY17 revenues increased by 4.9% in cc terms and 5.4% QoQ in US$ terms to US$152.6mn. EBITDA margins for the quarter were flattish QoQ at 17.5% even after robust revenue growth. Margin pressure was on account of INR appreciation (-66bps), visa costs (-42bps), billing rates decline amongst 3 of Top-5 clients (-90bps). HEXW indicated loss of business in one of the Top-5 accounts and billing rate decline in 3 of the Top-5 clients, which would an effect of the revenue and margin going forward. Utilisation for the quarter stood at 80.8% (78.9% in 1QCY17). EPS for the quarter (excluding ESOPs) increased by 12.6% QoQ to `4.5. Foreign exchange gain stood at `138mn vs. `16mn in 1Q. Vertical splits: Banking and Financial Services was up 6.9% QoQ, while Travel & Transportation was up 3.9%, Healthcare & Insurance was down 4.8% and Manufacturing & Consumer was up 4.3% respectively. Operating metrics details. 1) Europe was up 7.3% QoQ. America was up 4.4%, while RoW increased 14% QoQ. HEXW lost 2 clients on a net basis to take the list to 220. Top 5 clients were up 6.6% QoQ, while #6-10 were down 1.2%. 2) Offshore: onsite mix of revenue share changed in favour of onsite by 20bps QoQ to 35.3:64.7. 3) Attrition (LTM) decreased 110 bps QoQ to 13.8% in Q2CY17. 4) HEXW employed 13,098 professionals (364 net added QoQ), 5) Hexaware has forward contracts worth US$141.7mn @ `72.4/US$ and hedges worth 4mn @ `81.2/US$, GBP4.2mn @ `96.7/US$ maturing over next eight quarters. 6) DSO, billed and including unbilled accruals decreased 1 days and 4 days QoQ to 45 and 70 respectively. 7) HEXW has signed US$40mn worth of TCV deals (US$120mn in CY15, US$153mn in CY16, US$65mn in 1HCY17). 8) Services Lines Split: ADM was up 6.6%, Testing +4.2%, IMS +8.4% while Business Intelligence was up 7%. Enterprise Solutions was up just 1.1%. Guidance increased, but implies flattish growth for 2HCY17 CQGR: HEXW has increased its CY17 US$ revenue guidance to 14-15% (from 10-12% earlier), which implies 0-1% CQGR over 3Q-4QCY17, which is a muted guidance after robust revenue growth this quarter. Strong balance sheet, dividend payout lowered on account of preserving cash for acquisitions. Hexaware has US$66.5m in net cash (`14.5/share). Hexaware declared an interim dividend of `1/share (`5.5/share in CY16, `2/share in 1HCY17). It had declared dividends of `8.65 and `9.45 in CY15 and CY14. The dividend declared in CY15/CY16 amounted to a dividend payout ratio of 74/44% respectively. HEXW is looking at acquiring companies going ahead. We believe a dividend payout of ~50%+ over CY17/18E is sustainable, and we build dividend payouts of ~`7/7.5 per share in CY17/18E (HEXW wants to maintain a quarterly dividend yield). Valuation: The company inked new customer deals of US$40mn in 2QCY17, which instills confidence in revenue growth going ahead. Our revenue forecast for HEXW for CY16-18 is 13.9% CAGR. Stock valuations, at 16.9x/15.4x CY17/CY18E EPS, are rich leaving limited upside from the current level.

Exhibit 1: Quarterly details ` mn 2QCY16 1QCY17 2QCY17 QoQ (%) YoY (%) Comments Revenues (in US$ mn) 129.7 144.7 152.6 5.4 Cc increase of 4.9%. Top 5 clients were up 6.6% 17.7 QoQ, while #6-10 were down 1.2%. Revenues 8,697 9,605 9,836 2.4 13.1 - Operating costs 7,297 7,928 8,117 2.4 11.2 EBITDA 1,400 1,677 1,719 2.5 22.8 EBITDA margin (%) 16.1 17.5 17.5 2bps 138bps - Interest expense - - - - - - Depreciation 139 157 157 0.0 12.9 + Other income, net (incl forex) 132 28 146 421.4 10.6 PBT 1,393 1,548 1,708 10.3 22.6 - Taxes 347 355 363 2.3 4.6 Margin pressure was on account of INR appreciation (-66bps), visa costs (-42bps), billing rates decline amongst 3 of Top-5 clients (-90bps). OI breakup: Forex gain of `138mn in Q2 vs. `16mn in the last quarter. Effective tax rate (%) 24.9 22.9 21.3 (168)bps (366)bps Effective tax rate for CY17 to be between 23-24% PAT 1,046 1,193 1,345 12.7 28.6 Net margin (%) 12.0 12.4 13.7 125bps 165bps Reported profits 999 1,139 1,224 7.5 22.5 Exhibit 2: Change in estimates ` mn CY17E Hexaware took a hit of `121mn on account of a ESOP charge. CY18E Old New %Chg Old New %Chg Revenue (US$ mn) 605 609 0.7 682 677 (0.7) Revenue 39,976 39,681 (0.7) 45,010 43,997 (2.3) EBITDA margin (%) 17.6 17.3 (25)bps 17.7 17.5 (20)bps EPS (`) 16.1 15.5 (3.7) 18.5 17.0 (8.1) Source: Trust Research Geography wise Revenues: Europe was up 7.3% QoQ. America was up 4.4%, while RoW increased 14% QoQ. Exhibit 3: Geographical wise Performance Geographical mix Q2CY15 Q3CY15 Q4CY15 Q1CY16 Q2CY16 Q3CY16 Q4CY16 Q1CY17 Q2CY17 US 81.0 80.8 81.3 81.4 80.9 82.0 82.5 81.6 80.8 Europe 13.4 13.8 13.1 12.0 12.5 11.6 11.1 11.0 11.2 RoW 5.6 5.4 5.6 6.6 6.6 6.4 6.4 7.4 8.0 Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 Services wise Performance: Services Lines Split: ADM was up 6.6%, Testing +4.2%, IMS +8.4% while Business Intelligence was up 7%. Enterprise Solutions was up just 1.1%. 2

Exhibit 4: Service offering segmentation Details Q2CY15 Q3CY15 Q4CY15 Q1CY16 Q2CY16 Q3CY16 Q4CY16 Q1CY17 Q2CY17 Application dev & maintainence (ADM) 37.8 37.3 38.1 37.7 36.5 36.0 36.4 36.1 36.5 Enterprise application services (EAS) 14.3 14.6 14.3 13.7 13.3 13.0 12.7 12.1 11.6 Testing / QATS 20.9 20.8 20.6 20.3 20.1 20.3 20.9 20.9 19.7 Business intelligence & Analytics 15.1 14.7 14.0 15.2 15.6 15.2 14.1 13.8 14.0 BPO 5.2 5.7 5.7 5.8 6.5 6.8 6.8 6.4 7.2 Others 6.7 6.9 7.3 7.3 8.0 8.7 9.1 10.7 11.0 Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 Human Resources: Attrition (LTM) decreased 110 bps QoQ to 13.8% in Q2CY17. HEXW employed 13,098 professionals (364 net added QoQ). Exhibit 5: Employee strength at HEXW Details Q1CY16 Q2CY16 Q3CY16 Q4CY16 Q1CY17 Q2CY17 Onsite (%) 20.5 20.5 20.9 21.0 20.9 20.9 Offshore (%) 71.0 70.7 70.6 70.7 71.0 71.2 Total billable (%) 91.5 91.2 91.5 91.7 91.9 92.1 Marketing (Incl. sales support, %) 3.5 3.8 3.5 3.3 3.2 3.3 Others (Incl. sales support, %) 5.0 5.0 5.0 5.0 4.9 4.6 Total (%) 100.0 100.0 100.0 100.0 100.0 100.0 Headcount (Nos.) 11,599 11,875 11,859 12,115 12,734 13,098 Utilisation 69.6 70.0 74.1 78.6 78.9 80.8 Attrition 16.0 16.6 16.5 16.1 14.9 13.8, Trust Research Client Concentration: HEXW lost 2 clients on a net basis to take the list to 220. Top 5 clients were up 6.6% QoQ, while #6-10 were down 1.2%. Exhibit 6: Client details Details Q2CY15 Q3CY15 Q4CY15 Q1CY16 Q2CY16 Q3CY16 Q4CY16 Q1CY17 Q2CY17 Top 5 clients (%) 44.4 42.7 42.2 42.9 43.1 47.0 46.3 45.6 46.1 Top 10 clients (%) 56.1 54.4 54.7 55.3 55.2 58.3 57.4 56.7 56.5 > US$1m+ 62 65 69 73 76 77 78 81 81 Between US$1-5m 43 48 53 58 62 63 64 67 66 Between US$5-10m 10 8 7 6 6 6 6 6 7 Between US$10m-20m 5 8 5 5 3 3 3 3 3 Over US$20m+ 4 5 4 4 5 5 5 5 5 Clients added 9 9 9 10 6 7 7 6 9 Clients billed 225 223 226 229 226 222 220 222 220 3

1Q11 3Q11 1Q12 3Q12 1Q13 3Q13 1Q14 3Q14 1Q15 3Q15 1Q16 3Q16 1Q17 1Q11 3Q11 1Q12 3Q12 1Q13 3Q13 1Q14 3Q14 1Q15 3Q15 1Q16 3Q16 1Q17 Hexaware 2QCY17 Result Update 31 July 2017 Exhibit 7: Utilisation being used as margin lever 81 79 77 75 73 71 69 67 65 63 Exhibit 8: Attrition slowly going down 19 16 13 10 7, Trust, Trust Exhibit 9: Billed DSO decreased 1 day QoQ to 45 days; unbilled DSO s were down 4 days QoQ to 70 55 50 45 40 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17, Trust 4

Financials Income Statement (` mn) Year End-Dec CY14 CY15 CY16 CY17E CY18E Revenues 25,817 31,235 35,349 39,681 43,997 Op. Expenses 21,041 25,680 29,356 32,814 36,282 EBITDA 4,776 5,555 5,993 6,867 7,715 Other Income (90) 173 394 309 285 Depreciation 440 482 559 632 671 EBIT 4,246 5,246 5,828 6,544 7,329 Interest - - - - - PBT 4,246 5,246 5,828 6,544 7,329 Tax 980 1,114 1,411 1,507 1,759 PAT 3,266 4,132 4,417 5,037 5,570 Extra-ordinary items 66 200 246 417 484 Adj Pat 3,200 3,932 4,171 4,620 5,086 Valuations Summary Year End-Dec CY14 CY15 CY16E CY17E CY18E Per share (`) EPS (incl. ESOP charge) 10.9 13.7 14.6 15.5 17.0 CEPS 12.4 15.3 16.4 19.1 20.9 BVPS 43.1 47.5 56.5 62.3 70.5 DPS 9.5 8.7 5.5 7.0 7.5 Payout (%) 101.8 73.9 44.1 48.3 47.1 Valuation (x) P/E 22.3 17.9 13.5 16.9 15.4 P/BV 5.6 5.2 3.5 4.2 3.7 EV/EBITDA 13.9 12.2 9.0 10.5 9.1 Dividend Yield (%) 3.9 3.5 2.8 2.7 2.9 Return ratio (%) EBIDTA Margin 18.5 17.8 17.0 17.3 17.5 PAT Margin 12.7 13.2 12.5 12.7 12.7 ROAE 26.2 30.3 28.1 28.3 28.1 ROACE 34.8 38.5 37.1 36.7 37.0 Leverage Ratios (x) Net Debt/Equity (0.4) (0.4) (0.3) (0.3) (0.4) Current ratio 2.4 2.2 2.1 2.1 2.2 Growth Ratios (%) Income growth 13.0 21.0 13.2 12.3 10.9 EBITDA growth (6.8) 16.3 7.9 14.6 12.3 PAT growth (13.9) 26.5 6.9 14.0 10.6 Turnover Ratios F.A. Turnover 6.9 6.9 5.9 6.4 7.0 Debtors Days 55 56 48 48 47 Payable days 11 12 12 12 12 Balance Sheet (` mn) Year End-Dec CY14 CY15 CY16E CY17E CY18E Liabilities Equity Share Capital 602 603 604 593 593 Reserves & Surplus 12,304 13,729 16,507 17,949 20,492 Total Shareholders Fund 12,906 14,332 17,111 18,542 21,085 Non- current liabilties 144 82 182 74 121 Deferred tax liabilities (175) (270) (376) (376) (376) Other LT liabilties & prov 319 352 558 450 497 Current Liabilities 4,311 5,347 6,319 6,833 7,555 Trade payables 680 774 885 989 1,093 Other cur liabilities & Prov 3,631 4,573 5,434 5,844 6,461 Total Liabilities 17,361 19,761 23,612 25,448 28,760 Assets Non- current Assets 7,220 7,740 10,573 11,393 11,832 Fixed assets 3,730 3,880 6,030 6,180 6,330 Non-current investments 1,763 1,763 2,549 2,549 2,549 Long-term loans & adv 1,399 1,712 1,752 2,174 2,411 Other non-current assets 328 385 242 489 542 Current assets 10,140 12,021 13,039 14,055 16,928 Current investments 1,851 1,851 909 909 909 Trade receivables 3,656 4,279 4,376 4,892 5,424 Cash & bank balances 2,865 3,709 4,482 5,481 7,521 Short-term loans & adv 538 642 858 815 904 Other current assets 1,230 1,540 2,413 1,957 2,170 Total Assets 17,361 19,761 23,612 25,448 28,760 Cash flow Statement Year End-Dec CY14 CY15 CY16E CY17E CY18E PBT 4,246 5,246 5,828 6,544 7,329 Depreciation 217 387 439 632 671 Others (66) (200) (246) (417) (484) CF before W.cap 4,397 5,433 6,021 6,759 7,516 Inc/dec in W.cap 2,245 337 (545) 282 354 Op CF after W.cap 2,152 5,096 6,566 6,478 7,162 Less Taxes 980 1,114 1,411 1,507 1,759 Net CF From Operations 1,172 3,982 5,155 4,970 5,403 Inc/(dec) in F.A + CWIP 493 632 2,050 782 821 (Pur)/sale of Investments (1,462) - 1,095 - - CF from Invst Activities 969 (632) (3,145) (782) (821) Equity Raised 1,037 547 558 (756) 78 Dividend 3,323 3,053 1,950 2,433 2,621 CF from Fin Activities (2,286) (2,506) (1,392) (3,190) (2,543) Net inc /(dec) in cash (146) 999 618 999 2,040 Op. bal of cash 3,011 2,865 3,864 4,482 5,481 Cl. balance of cash 2,865 3,864 4,482 5,481 7,521 5

Institutional Equity Team Names Designation Sectors Email ID's Desk-Number Naren Shah Head Of Equity naren.shah@trustgroup.in +91-22-4084-5074 Sales Trading & Dealing Rajesh Ashar Sales Trader rajesh.ashar@trustgroup.in +91-22-4224-5123 Dealing Desk trustfin@bloomberg.net +91-22-4084-5089 Research Team Binyam Taddese Analyst Rates & Credit Research binyam.taddese@trustgroup.in +91-22-4224-5037 Naushil Shah Analyst Technology, Media & Telecom naushil.shah@trustgroup.in +91-22-4224-5125 Tushar Chaudhari Analyst Commodities, Auto & Mid-caps tushar.chaudhari@trustgroup.in +91-22-4224-5119 Ritu Chaudhary Associate Consumer Durable & FMCG ritu.chaudhary@trustgroup.in +91-22-4224-5183 6

DISCLAIMER This document has been prepared by Trust Financial Consultancy Services Private Limited (hereinafter referred to as TFCSPL) to provide information about the company (ies) and/sector(s), if any, covered in the report. This report is for personal information of the selected recipient/s and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and TFCSPL is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. Information and opinions presented in this report were obtained or derived from sources that TFCSPL believes to be reliable, but TFCSPL makes no representations or warranty, express or implied, as to their accuracy or completeness or correctness. TFCSPL accepts no liability for loss arising from the use of the material pres ented in this report, except that this exclusion of liability does not apply to the extent that liability arises under specific statutes or regulations applicable to TFCSPL. Information, opinions and estimates contained in this report reflect a judgment of its original date of publication by TFCSPL and are subject to change without notice. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Other Disclosures by Trust Financial Consultancy Services Private Limited (hereinafter referred to as TFCSPL) under SEBI (Research Analysts) Regulations, 2014 with reference to the subject companies(s) covered in this report: TFCSPL is engaged in the business of Retail & Institutional Stock Broking. TFCSPL is a member of the National Stock Exchange of India Limited, BSE Limited and Metropolitan Stock Exchange of India Limited. The associate/subsidiary companies of TFCSPL are engaged in the businesses of Merchant Banking, portfolio management, lending, wealth management etc. TFCSPL s activities were neither suspended nor has it defaulted with any stock exchange authority with whom it has been registered in the last five years. TFCSPL has not been debarred from doing business by any Stock Exchange / SEBI or any other authority. No disciplinary action has been taken by any regulatory authority against TFCSPL impacting its equity research analysis activities. TFCSPL and it s associate/subsidiary companies may have managed or co-managed public offering of securities, may have received compensation for merchant banking or brokerage services, may have received any compensation for products or services other than merchant banking or brokerage services from the subject company in the past 12 months. TFCSPL and it s associate/subsidiary companies have not received any compensation or other benefits from the subject company or third party in connection with the research report. Subject Company may have been a client of TFCSPL or its associate/subsidiary companies during twelve months preceding the date of distribution of the research report. TFCSPL and/or its associate/subsidiary companies and/or employees may have interests/positions, financial or otherwise of over 1 % at the end of the month immediately preceding the date of publication of the research in the securities mentioned in this report. TFCSPL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014. SEBI Reg. No. INH000001543. Analyst Certification: The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject company securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of TFCSPL research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues Disclosure of Interest Statement Analyst Ownership of Stock Served as Director or Employee Name of Company No No Stock Ratings are defined as follows :- Recommendation Interpretation Recommendation Expected absolute returns (%) over 12 months Buy More than 15% Hold 15% to -15% Sell Less than -15% Regional Disclosures (outside India): This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject TFCSPL or its associate/ subsidiary companies to registration or licensing requirements within such jurisdictions. 7